Developer docs
API playgroundTry for free, no card

Search company profiles

Dermapharm AG

Full company profile

uuid00499er

Namestring
Dermapharm AG
Legal namestring
Dermapharm AG
Websiteurl
dermapharm.ch
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Dermapharm AG is a Swiss pharmaceutical company founded in 1995 and headquartered in Hünenberg ZG. It operates as the Swiss subsidiary of the Dermapharm Unternehmensgruppe, a family-managed German corporate group. The company's core business is the development, manufacturing, and distribution of high-quality dermatological and anti-inflammatory pharmaceutical products, with its own production facility located in Brehna, Germany. It positions itself as a reliable partner for patients, doctors, pharmacists, and other stakeholders in the Swiss national healthcare system, operating through a sales-led, relationship-driven distribution model that routes products via the Swiss pharmacy network under Swiss pharmaceutical regulations.

The company has expanded its Swiss portfolio through three strategic acquisitions: Allergopharma AG in 2021 (allergy medications), Arkopharma AG (Arko Diffusion SA) in 2023 (phytotherapy and dietary supplements), and Candoro ethics AG in 2023 (narcotics and controlled substances). These integrations have systematically broadened Dermapharm AG's therapeutic footprint beyond dermatology into adjacent pharmaceutical categories, while drawing on the parent group's broader portfolio of brands including mibe arzneimittel, Strathmann, Trommsdorff, huebner naturarzneimittel, axi corp pharma, and acis.

Dermapharm AG is a private company with no publicly disclosed revenue, headcount, or pricing data. Revenue mechanics are based on pharmaceutical product sales through the Swiss healthcare and pharmacy channel, with three integrated acquired brands contributing to top-line diversification. The company's addressable market is the Swiss national healthcare system, and its geographic focus remains domestic despite the parent group's broader European presence.

Short descriptiontext

Dermapharm AG is a Swiss pharmaceutical subsidiary founded in 1995 that develops, manufactures, and distributes dermatological, anti-inflammatory, allergy, phytotherapy, and narcotics products for the Swiss healthcare market from its Hünenberg headquarters.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHünenberg ZG, Switzerland
HQ citystring
Hünenberg ZG
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermatological pharmaceuticals, anti-inflammatory medicines, pharmaceutical manufacturing, allergy medications, phytotherapy supplements
Industry4 codes
PRIMARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAF
Pulmonology & Allergy Specialty Pharmaceuticals
SECONDARYHLAIABAE
Topical & Dermatology Generics
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Medicinal Chemicals & Botanical Products2833
Product category
Dermatological Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Development and Distribution
TypeOne Time License
Description

Development, manufacturing, and distribution of high-quality dermatological and anti-inflammatory pharmaceutical products. The company operates through its Swiss subsidiary to serve the Swiss market.

dermapharm.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Operations, Personnel, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1mibe arzneimittel
Description

Pharmaceutical company within the Dermapharm group

dermapharm.com
+8 more records
Core offering1 text field

Dermapharm AG develops, manufactures, and distributes high-quality dermatological and anti-inflammatory pharmaceutical products for the Swiss healthcare market. Through its own pharmaceutical production facility in Brehna, Germany, and acquired brands (Allergopharma, Arkopharma, Candoro ethics), the company offers a portfolio spanning dermatology, allergy, phytotherapy/dietary supplements, and narcotics to patients, doctors, pharmacists, and national healthcare stakeholders in Switzerland.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Dermapharm AG is a family-owned pharmaceutical company founded in 1995, based in Hünenberg ZG, Switzerland, with its own pharmaceutical production facility in Brehna, Germany. The company operates as a single brand portfolio focused on high-quality dermatological and anti-inflammatory medications for the Swiss healthcare market. The Dermapharm group has expanded through strategic acquisitions: Allergopharma AG (2021) for allergy treatments, Arkopharma AG (2023) for phytotherapy and dietary supplements, and Candoro ethics AG (2023) for narcotics. The group encompasses multiple subsidiaries including mibe arzneimittel, Strathmann, Trommsdorff, Mibetec, axi corp pharma, huebner naturarzneimittel, and acis, all serving various segments of the pharmaceutical industry across Europe.

Product and service4 records
1Dermatological and Anti-inflammatory Pharmaceuticals
CategoryDermatological Pharmaceuticals
Description

High-quality dermatological and anti-inflammatory pharmaceutical products manufactured at the group's own production facility in Brehna, Germany, and distributed to patients, doctors, pharmacists, and stakeholders in the Swiss national healthcare system.

2Allergopharma AG - Allergy Pharmaceuticals
CategoryAllergy Pharmaceuticals
Description

Allergy-focused pharmaceutical products distributed under the Allergopharma brand, serving patients, doctors, and pharmacists in Switzerland with allergy therapeutics.

3Arkopharma AG (Arko Diffusion SA) - Phytotherapy and Dietary Supplements
CategoryPhytotherapy and Dietary Supplements
Description

Phytotherapy and dietary supplement products distributed under the Arkopharma brand in Switzerland, providing herbal medicines and nutritional supplements to patients and pharmacy partners.

4Candoro ethics AG - Narcotics/Anaesthetics Pharmaceuticals
CategoryControlled Substances / Narcotics Pharmaceuticals
Description

Narcotics and anaesthetics pharmaceutical products distributed under the Candoro ethics brand, serving controlled-substance prescribing and dispensing needs in the Swiss healthcare system.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Acquired in 2023, Arkopharma AG expanded Dermapharm's competencies in phytotherapy and nutritional supplements in the Swiss market.

2Candoro ethics AG
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Acquired in 2023, Candoro ethics AG expanded Dermapharm's competencies in controlled substances/narcotics in the Swiss market.

dermapharm.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acquired in 2021, Allergopharma AG expanded Dermapharm's competencies in the allergy sector within the Swiss market.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Swiss pharmaceutical wholesale and distribution company serving pharmacies, physicians, and hospitals. Comparable to Dermapharm AG as a Switzerland-focused pharmaceutical distribution counterpart with overlapping Swiss pharmacy channel presence.

TypeBroad incumbent
Description

Global consumer healthcare company with dermatology and oral health franchises. Comparable to Dermapharm AG in pharmacy-channel distribution and OTC dermatology, though at significantly larger scale and broader category breadth.

TypeDirect peer
Description

Global dermatology-focused pharmaceutical company with a broad prescription and aesthetics portfolio. Directly comparable to Dermapharm AG's core dermatology franchise and Swiss market presence through prescription dermatology products sold via pharmacies.

TypeDirect peer
Description

European dermatology-focused pharmaceutical company with a portfolio of prescription and dermo-cosmetic products. Comparable to Dermapharm AG in mid-sized dermatology player positioning, pharmacy-channel distribution, and emphasis on inflammatory skin conditions.

TypeDirect peer
Description

French pharmaceutical and dermo-cosmetic group with a leading dermatology franchise. Comparable to Dermapharm AG in the combination of prescription dermatology, dermo-cosmetics, and integrated manufacturing for skin-care products sold through pharmacy channels.

TypeDirect peer
Description

Specialist dermatology pharmaceutical company with strong prescription portfolios in psoriasis, eczema, and skin infections. Comparable to Dermapharm AG in therapeutic focus, channel model (specialists and pharmacies), and regulatory positioning across European markets including Switzerland.

7Bayer Consumer Health
TypeBroad incumbent
Description

Major pharmaceutical and consumer health player with dermatology and skin-care brands (e.g., Bepanthen). Comparable to Dermapharm AG as an incumbent selling dermatology products through Swiss pharmacies, though within a much larger diversified portfolio.

TypeRegional player
Description

Swiss dermatology pharmaceutical and dermo-cosmetic company with a strong local footprint. Highly comparable to Dermapharm AG in Swiss-market-only focus, dermatology and skin-care product categories, and pharmacy-channel distribution model.

TypeDirect peer
Description

European generics and specialty pharmaceutical company with a strong dermatology and consumer health portfolio. Comparable to Dermapharm AG in the combination of branded generics, specialty pharma, and broad European pharmacy distribution including Switzerland.

TypeBroad incumbent
Description

German parent company of Dermapharm AG and a publicly listed pharmaceutical group with a portfolio spanning dermatology, allergy, vitamins, and generics. Closely related through shared ownership and shared production facility in Brehna; serves as the umbrella entity whose strategy shapes Dermapharm AG's direction.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dermapharm AG

Dermatological Pharmaceuticalsdermapharm.ch

Dermapharm AG is a Swiss pharmaceutical subsidiary founded in 1995 that develops, manufactures, and distributes dermatological, anti-inflammatory, allergy, phytotherapy, and narcotics products for the Swiss healthcare market from its Hünenberg headquarters.

What Dermapharm AG does

Dermapharm AG is a Swiss pharmaceutical company founded in 1995 and headquartered in Hünenberg ZG. It operates as the Swiss subsidiary of the Dermapharm Unternehmensgruppe, a family-managed German corporate group. The company's core business is the development, manufacturing, and distribution of high-quality dermatological and anti-inflammatory pharmaceutical products, with its own production facility located in Brehna, Germany. It positions itself as a reliable partner for patients, doctors, pharmacists, and other stakeholders in the Swiss national healthcare system, operating through a sales-led, relationship-driven distribution model that routes products via the Swiss pharmacy network under Swiss pharmaceutical regulations.

The company has expanded its Swiss portfolio through three strategic acquisitions: Allergopharma AG in 2021 (allergy medications), Arkopharma AG (Arko Diffusion SA) in 2023 (phytotherapy and dietary supplements), and Candoro ethics AG in 2023 (narcotics and controlled substances). These integrations have systematically broadened Dermapharm AG's therapeutic footprint beyond dermatology into adjacent pharmaceutical categories, while drawing on the parent group's broader portfolio of brands including mibe arzneimittel, Strathmann, Trommsdorff, huebner naturarzneimittel, axi corp pharma, and acis.

Dermapharm AG is a private company with no publicly disclosed revenue, headcount, or pricing data. Revenue mechanics are based on pharmaceutical product sales through the Swiss healthcare and pharmacy channel, with three integrated acquired brands contributing to top-line diversification. The company's addressable market is the Swiss national healthcare system, and its geographic focus remains domestic despite the parent group's broader European presence.

Dermapharm AG firmographics

Firmographics
Name
Dermapharm AG
Legal name
Dermapharm AG
Website
https://dermapharm.ch
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
101–250 employees
Short description
Dermapharm AG is a Swiss pharmaceutical subsidiary founded in 1995 that develops, manufactures, and distributes dermatological, anti-inflammatory, allergy, phytotherapy, and narcotics products for the Swiss healthcare market from its Hünenberg headquarters.
Ownership category
akta.pro rank

Dermapharm AG industry classification

Industry
Product category
Dermatological Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAF
Pulmonology & Allergy Specialty Pharmaceuticals
SECONDARYHLAIABAE
Topical & Dermatology Generics

Keywords

  • Dermatological pharmaceuticals
  • Anti-inflammatory medicines
  • Pharmaceutical manufacturing
  • Allergy medications
  • Phytotherapy supplements

Where Dermapharm AG is headquartered

Location

Headquarters

HQ city
Hünenberg ZG
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Dermapharm AG business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

  1. Pharmaceutical Development and Distribution: Development, manufacturing, and distribution of high-quality dermatological and anti-inflammatory pharmaceutical products. The company operates through its Swiss subsidiary to serve the Swiss market.

Go-to-market motion1 record

Distribution channels1 record

Dermapharm AG product offering

Product offering

Core offering

Dermapharm AG develops, manufactures, and distributes high-quality dermatological and anti-inflammatory pharmaceutical products for the Swiss healthcare market. Through its own pharmaceutical production facility in Brehna, Germany, and acquired brands (Allergopharma, Arkopharma, Candoro ethics), the company offers a portfolio spanning dermatology, allergy, phytotherapy/dietary supplements, and narcotics to patients, doctors, pharmacists, and national healthcare stakeholders in Switzerland.

Product overview

Dermapharm AG is a family-owned pharmaceutical company founded in 1995, based in Hünenberg ZG, Switzerland, with its own pharmaceutical production facility in Brehna, Germany. The company operates as a single brand portfolio focused on high-quality dermatological and anti-inflammatory medications for the Swiss healthcare market. The Dermapharm group has expanded through strategic acquisitions: Allergopharma AG (2021) for allergy treatments, Arkopharma AG (2023) for phytotherapy and dietary supplements, and Candoro ethics AG (2023) for narcotics. The group encompasses multiple subsidiaries including mibe arzneimittel, Strathmann, Trommsdorff, Mibetec, axi corp pharma, huebner naturarzneimittel, and acis, all serving various segments of the pharmaceutical industry across Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • mibe arzneimittel: Pharmaceutical company within the Dermapharm group
  • strathmann
  • Trommsdorff
  • allergopharma
  • candoro ethics
  • mibetec
  • axicorp pharma
  • huebner naturarzneimittel
  • acis

Products and services

  • Dermatological and Anti-inflammatory Pharmaceuticals High-quality dermatological and anti-inflammatory pharmaceutical products manufactured at the group's own production facility in Brehna, Germany, and distributed to patients, doctors, pharmacists, and stakeholders in the Swiss national healthcare system.
  • Allergopharma AG - Allergy Pharmaceuticals Allergy-focused pharmaceutical products distributed under the Allergopharma brand, serving patients, doctors, and pharmacists in Switzerland with allergy therapeutics.
  • Arkopharma AG (Arko Diffusion SA) - Phytotherapy and Dietary Supplements Phytotherapy and dietary supplement products distributed under the Arkopharma brand in Switzerland, providing herbal medicines and nutritional supplements to patients and pharmacy partners.
  • Candoro ethics AG - Narcotics/Anaesthetics Pharmaceuticals Narcotics and anaesthetics pharmaceutical products distributed under the Candoro ethics brand, serving controlled-substance prescribing and dispensing needs in the Swiss healthcare system.

Companies that use Dermapharm AG

Customer profile

Segments3 records

Ideal customer profiles1 record

Dermapharm AG technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Dermapharm AG partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Arkopharma AG (Arko Diffusion SA)coreStrategic or Co-development Partner · 1 January 2023Acquired in 2023, Arkopharma AG expanded Dermapharm's competencies in phytotherapy and nutritional supplements in the Swiss market.
  • Candoro ethics AGcoreStrategic or Co-development Partner · 1 January 2023Acquired in 2023, Candoro ethics AG expanded Dermapharm's competencies in controlled substances/narcotics in the Swiss market.
  • Allergopharma AGcoreStrategic or Co-development Partner · 1 January 2021Acquired in 2021, Allergopharma AG expanded Dermapharm's competencies in the allergy sector within the Swiss market.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Dermapharm AG competitors and assessment

Company assessment

Regional players

  • Hänseler AG: Swiss pharmaceutical wholesale and distribution company serving pharmacies, physicians, and hospitals. Comparable to Dermapharm AG as a Switzerland-focused pharmaceutical distribution counterpart with overlapping Swiss pharmacy channel presence.
  • Spirig HealthCare AG: Swiss dermatology pharmaceutical and dermo-cosmetic company with a strong local footprint. Highly comparable to Dermapharm AG in Swiss-market-only focus, dermatology and skin-care product categories, and pharmacy-channel distribution model.

Broad incumbents

  • Haleon: Global consumer healthcare company with dermatology and oral health franchises. Comparable to Dermapharm AG in pharmacy-channel distribution and OTC dermatology, though at significantly larger scale and broader category breadth.
  • Bayer Consumer Health: Major pharmaceutical and consumer health player with dermatology and skin-care brands (e.g., Bepanthen). Comparable to Dermapharm AG as an incumbent selling dermatology products through Swiss pharmacies, though within a much larger diversified portfolio.
  • Dermapharm Holding SE: German parent company of Dermapharm AG and a publicly listed pharmaceutical group with a portfolio spanning dermatology, allergy, vitamins, and generics. Closely related through shared ownership and shared production facility in Brehna; serves as the umbrella entity whose strategy shapes Dermapharm AG's direction.

Direct peers

  • Galderma: Global dermatology-focused pharmaceutical company with a broad prescription and aesthetics portfolio. Directly comparable to Dermapharm AG's core dermatology franchise and Swiss market presence through prescription dermatology products sold via pharmacies.
  • Almirall: European dermatology-focused pharmaceutical company with a portfolio of prescription and dermo-cosmetic products. Comparable to Dermapharm AG in mid-sized dermatology player positioning, pharmacy-channel distribution, and emphasis on inflammatory skin conditions.
  • Pierre Fabre: French pharmaceutical and dermo-cosmetic group with a leading dermatology franchise. Comparable to Dermapharm AG in the combination of prescription dermatology, dermo-cosmetics, and integrated manufacturing for skin-care products sold through pharmacy channels.
  • LEO Pharma: Specialist dermatology pharmaceutical company with strong prescription portfolios in psoriasis, eczema, and skin infections. Comparable to Dermapharm AG in therapeutic focus, channel model (specialists and pharmacies), and regulatory positioning across European markets including Switzerland.
  • Stada Arzneimittel AG: European generics and specialty pharmaceutical company with a strong dermatology and consumer health portfolio. Comparable to Dermapharm AG in the combination of branded generics, specialty pharma, and broad European pharmacy distribution including Switzerland.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Dermapharm AG social profiles

Digital presence

Dermapharm AG financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dermapharm AG leadership team

Management profile

Number of profiles

Dermapharm AG subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Dermapharm AG funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dermapharm AG M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dermapharm AG

What does Dermapharm AG do?

Dermapharm AG develops, manufactures, and distributes high-quality dermatological and anti-inflammatory pharmaceutical products for the Swiss healthcare market. Through its own pharmaceutical production facility in Brehna, Germany, and acquired brands (Allergopharma, Arkopharma, Candoro ethics), the company offers a portfolio spanning dermatology, allergy, phytotherapy/dietary supplements, and narcotics to patients, doctors, pharmacists, and national healthcare stakeholders in Switzerland.

Is Dermapharm AG a public or private company?

Dermapharm AG is a private company. It is classified as family owned and is currently operating.

When was Dermapharm AG founded?

Dermapharm AG was founded in 1995. It employs 101 to 250 people.

Where is Dermapharm AG based?

Dermapharm AG is headquartered in Hünenberg ZG, Switzerland, in the Europe region.

How does Dermapharm AG make money?

One revenue line is on record: pharmaceutical Development and Distribution.

Who are Dermapharm AG's main competitors?

Regional players on record are Hänseler AG and Spirig HealthCare AG. Broad incumbents are Haleon, Bayer Consumer Health and Dermapharm Holding SE. Direct peers are Galderma, Almirall, Pierre Fabre, LEO Pharma and Stada Arzneimittel AG.

Does Dermapharm AG have an API?

No public API is recorded for Dermapharm AG.

What industry is Dermapharm AG in?

Dermapharm AG's product category is Dermatological Pharmaceuticals. Its primary akta.pro industry code is HLAIACAL, Dermatology Specialty Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales